Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively.

Source:http://linkedlifedata.com/resource/pubmed/id/10738260

Int. J. Cancer 2000 Apr 15 86 2 295-7

Download in:

View as

General Info

PMID
10738260